Polycystic Ovarian Syndrome (PCOS) has had a recent name change to Polyendocrine Metabolic Ovarian Syndrome (PMOS) - talk about a name glow up!

We welcome the new name change as its a shift to a whole-body health and medical perspective. PMOS doesn't just impact the hormones, it impacts multiple body systems, including hormones, metabolism, and mental health, rather than just the ovaries.

This episode is dedicated to discussing the details of the new name change as-well as recapping the diagnostic criteria, PMOS phenotypes (spoiler alert, you can be more than one phenotype), and what treatment/management actually looks like when you're in clinic dealing with it in real life.

TW: Eating Disorders

• We also make note of the large Australian cohort study (n=8,467) which found a significant association between PMOS and an increased link to disordered eating and eating disorders such as bulimia nervosa, binge eating.

Episode Resources

• Rotterdam Criteria
• PMOS Phenotypes Explained
  • Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomes
• Lancet Article: Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process
• PMID: 31056307
• Catch our other episode with Endocrinologist Dr Soji Swaraj: Polycystic Ovarian Syndrome (PCOS) Across The Lifespan

Throughout this episode, we use the term 'women' when discussing PMOS. We acknowledge this language may not reflect the identities of all listeners, including those assigned female at birth (AFAB) who do not identify as women but who may also experience PMOS. Additionally, where we cite research or studies on PMOS that do not distinguish between gender identity categories, we use 'women' to remain consistent with the original source material. This terminology choice is not intended to exclude or erase any individual's experience.

As always, we'd love to hear from you. Send us a DM on Instagram or email us at hello@hormonehealthstudio.com.